@FiercePharma: GeneOne, Inovio's MERS vaccine enters PhI at Walter Reed. Story | Follow @FiercePharma
@EricPFierce: ICYMI: #Novo makes sure Denmark gets some of the action as it starts massive build up. More | Follow @EricPFierce
@CarlyHFierce: $GSK shoots for diabetes-esque platform approach with new respiratory med in hand. Article | Follow @CarlyHFierce
> Leo Pharma agreed to shell out €675 million ($723 million) for Astellas' global dermatology portfolio, including the eczema drug Protopic and other products for acne and skin infections. Release
> Citron Research chief Andrew Left said his firm has a short position in Mallinckrodt ($MNK), the drugmaker Citron criticized as "a worse offender" than Valeant in a tweet on Monday. Report
> AstraZeneca ($AZN) priced a $6 billion bond issue to fund its planned buyout of ZS Pharma ($ZSPH). Report
Medical Device News
@FierceMedDev: Medtronic reports strong leadless pacemaker data as it races St. Jude to FDA approval. More | Follow @FierceMedDev
@VarunSaxena2: IYCMI from FierceDrugDelivery: Physicians call for novel abuse-deterrent opioid agonist/antagonist formulations in survey. Article | Follow @VarunSaxena2
@EmilyWFierce: Theranos and Safeway split after $350M deal, code-named "T-Rex," falls through. More from the WSJ | Follow @EmilyWFierce
> AliveCor adds former Google exec as CEO to further consumer ECG push. Articles
> Stanford engineers develop touch-free ultrasound device for tumor detection. More
Biotech News
@FierceBiotech: KIT team points pancreatic cancer therapy toward clinical trials. FierceBiotechResearch article | Follow @FierceBiotech
@JohnCFierce: Ex-Lumena gang pilots new course at Amplyx with antifungal R&D, $40.5M. Report | Follow @JohnCFierce
@DamianFierce: $HZNP "is threatening $ESRX's profiteering and exposing ... a lack of care for patients and respect for physicians." Release | Follow @DamianFierce
> Wave and Voyager keep the IPO train rolling, raising $172M in Wall Street debuts. More
> Boehringer slashes its R&D budget with a new focus on collaboration. Article
Biotech Research News
> MD Anderson group tracks 'modest' impact of lymphoma drug. Item
> Warp Drive Bio constructs a new cancer R&D tech platform. Story
> Microbiome study highlights bacterial strategy for treating severe diarrhea. News
> Case Western researchers spotlight role of rapid protein movement in hearing loss. More
> KIT team points pancreatic cancer therapy toward clinical trials. Article
Vaccines News
> GeneOne, Inovio's MERS vaccine enters PhI at Walter Reed. News
> MenAfriVac succeeds in sub-Saharan Africa, but the fight isn't over yet. More
> James Cook University researcher wins $2M Gates grant for malaria vaccine development. Story
> Novavax kicks off PhIII trial for its RSV vaccine. Article
> EMA safety review raises no issues with HPV vaccines from Merck, GSK. Report
Pharma Marketing News
> $1-per-pill alternative to Turing drug gets 'overwhelming' response: Imprimis CEO. Article
> Medivation's Xtandi sales force due for hiring, revamp as urology push falls flat. Report
> GSK shoots for diabetes-esque platform approach with new respiratory med in hand. More
> Allergan counting on January formulary boost to jump-start Namzaric launch. Story
> AstraZeneca holds on to purple Nexium trademark with early court win. Article
And Finally... More health systems are getting into the insurance business. Report